Sleep apnoea sufferers will soon be able to rest easier at night with a new fabric mask, one of several innovations the ASX-listed medical devicemaker is introducing, its chief executive says.
The CPAP maker recently announced its revenue last quarter jumped 11 per cent to $US1.2 billion ($1.8 billion), with gross margins improving and income from operations rising by more than a third.
